Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010:2010:695104.
doi: 10.1155/2010/695104. Epub 2010 Jun 20.

Search for Anti-EA(D) Antibodies in Subjects with an "Isolated VCA IgG" Pattern

Affiliations

Search for Anti-EA(D) Antibodies in Subjects with an "Isolated VCA IgG" Pattern

Massimo De Paschale et al. Int J Microbiol. 2010.

Abstract

The presence of an "isolated viral capsid antigen (VCA) IgG" pattern in serum is not easy to interpret without the aid of further tests, such as specific immunoblotting or a virus genome search, that often give rise to organisational and economic problems. However, one alternative is to use an enzyme-linked immunosorbent assay (ELISA) to detect anti-early antigen (EA) antibodies, which can be found in about 85% of subjects with acute Epstein-Barr virus (EBV) infections. The purpose of this work was to search for anti-EA(D) antibodies in 130 samples with an isolated VCA IgG pattern at ELISA screening and classified as being indicative of past (102 cases) or acute (28 cases) infection on the basis of the immunoblotting results. Thirty-seven samples (28.5%) were positive for anti-EA(D), of which 25 (89.3%) had been classified by immunoblotting as indicating acute and 12 (11.8%) past EBV infection. This difference was statistically significant (P < .01). The results of our search for anti-EA(D) antibodies correctly identified nearly 90% of acute (presence) or past EBV infections (absence). When other tests are not available, the search for anti-EA antibodies may therefore be helpful in diagnosing patients with an isolated VCA IgG pattern at screening tests.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Macsween KF, Crawford DH. Epstein-Barr virus—recent advances. Lancet Infectious Diseases. 2003;3(3):131–140. - PubMed
    1. Svahn A, Magnusson M, Jägdahl L, Schloss L, Kahlmeter G, Linde A. Evaluation of three commercial enzyme-linked immunosorbent assays and two latex agglutination assays for diagnosis of primary Epstein-Barr virus infection. Journal of Clinical Microbiology. 1997;35(11):2728–2732. - PMC - PubMed
    1. Gärtner BC, Hess RD, Bandt D, et al. Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method. Clinical and Diagnostic Laboratory Immunology. 2003;10(1):78–82. - PMC - PubMed
    1. de Paschale M, Agrappi C, Manco MT, Mirri P, Viganò EF, Clerici P. Seroepidemiology of EBV and interpretation of the "isolated VCA IgG" pattern. Journal of Medical Virology. 2009;81(2):325–331. - PubMed
    1. Bauer G. The rational basis for efficient Epstein-Barr virus (EBV) serology. Clinical Laboratory. 1995;41(9):623–634.

LinkOut - more resources